Radiotherapy-induced secondary malignancies for nasopharyngeal carcinoma: a pilot study of patients treated via IMRT or VMAT

Patients treated with radiotherapy are at risk of developing a second cancer during their lifetime, which can directly impact treatment decision-making and patient management. The aim of this study was to qualify and compare the secondary cancer risk after intensity-modulated radiation therapy and volumetric-modulated arc therapy in nasopharyngeal carcinoma patients.
Dove Medical Press